Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. Hosting Providers
  16. CDN Services

We are analyzing https://www.nature.com/articles/s41583-019-0240-3.

Title:
Amyloid-β-independent regulators of tau pathology in Alzheimer disease | Nature Reviews Neuroscience
Description:
The global epidemic of Alzheimer disease (AD) is worsening, and no approved treatment can revert or arrest progression of this disease. AD pathology is characterized by the accumulation of amyloid-β (Aβ) plaques and tau neurofibrillary tangles in the brain. Genetic data, as well as autopsy and neuroimaging studies in patients with AD, indicate that Aβ plaque deposition precedes cortical tau pathology. Because Aβ accumulation has been considered the initial insult that drives both the accumulation of tau pathology and tau-mediated neurodegeneration in AD, the development of AD therapeutics has focused mostly on removing Aβ from the brain. However, striking preclinical evidence from AD mouse models and patient-derived human induced pluripotent stem cell models indicates that tau pathology can progress independently of Aβ accumulation and arises downstream of genetic risk factors for AD and aberrant metabolic pathways. This Review outlines novel insights from preclinical research that implicate apolipoprotein E, the endocytic system, cholesterol metabolism and microglial activation as Aβ-independent regulators of tau pathology. These factors are discussed in the context of emerging findings from clinical pathology, functional neuroimaging and other approaches in humans. Finally, we discuss the implications of these new insights for current Aβ-targeted strategies and highlight the emergence of novel therapeutic strategies that target processes upstream of both Aβ and tau. In Alzheimer disease, the accumulation of amyloid-β (Aβ) is thought to drive both tau pathology and neurodegeneration. In this Review, van der Kant et al. discuss the evidence for Aβ-independent drivers of tau pathology in Alzheimer disease and the implications for therapeutic development.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$63,100 per month
Our analysis indicates Nature.com generates between $42,042 and $115,616 monthly online from display ads.

Keywords {🔍}

pubmed, google, scholar, cas, disease, central, alzheimers, tau, alzheimer, pathology, amyloid, brain, cell, nature, nat, human, apoe, mouse, study, neurol, amyloidβ, neurosci, neurons, pet, protein, model, app, accumulation, cholesterol, mice, med, microglia, risk, neuron, mol, precursor, article, neurodegeneration, stem, clinical, cognitive, biol, models, sci, rep, van, plaques, genetic, apolipoprotein, neuropathol,

Topics {✒️}

/news-releases/news-release-details/biogen-plans-regulatory-filing-aducanumab-alzheimers-disease /news-releases/news-release-details/biogen nature portfolio journals permissions reprints /media-centre/press-releases/2018/update nature portfolio privacy policy editing β-secretase c-terminal fragment /media/releases/med-cor-2019-01-30 advertising author information authors /science/index genome-wide meta-analysis identifies discontinue-phase-iii-clinical-studies cognitive research human ipsc-derived neurons preclinical research research & therapy apoe4-induced recycling block basic research regional amyloid deposition hydroxymethylglutaryl-coa reductase inhibitor nature+ nature 549 nature 374 nature 482 nature 515 nature anti-tau monoclonal antibody increased tau-pet levels amyloid-positive older individuals rapid single-step induction published maps small-molecule structure corrector small-molecule structure correctors ipsc-based compound screening author correspondence national library apoeε4 hipsc-derived neurons model-guided microarray implicates amyloid-β-independent regulators phase-iii-clinical-trials hipsc-derived ad neurons reduces beta-amyloid deposition amyloid-β-targeting therapies trem2–apoe pathway drives regional brain hypometabolism eisai-discontinue-phase-3-engage β-ctf fragment accumulation

Questions {❓}

  • Alzheimer’s genetic risk is reduced in primary age-related tauopathy: a potential model of resistance?
  • The A4 study: stopping AD before symptoms begin?
  • The amyloid cascade hypothesis: are we poised for success or failure?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Amyloid-β-independent regulators of tau pathology in Alzheimer disease
         description:The global epidemic of Alzheimer disease (AD) is worsening, and no approved treatment can revert or arrest progression of this disease. AD pathology is characterized by the accumulation of amyloid-β (Aβ) plaques and tau neurofibrillary tangles in the brain. Genetic data, as well as autopsy and neuroimaging studies in patients with AD, indicate that Aβ plaque deposition precedes cortical tau pathology. Because Aβ accumulation has been considered the initial insult that drives both the accumulation of tau pathology and tau-mediated neurodegeneration in AD, the development of AD therapeutics has focused mostly on removing Aβ from the brain. However, striking preclinical evidence from AD mouse models and patient-derived human induced pluripotent stem cell models indicates that tau pathology can progress independently of Aβ accumulation and arises downstream of genetic risk factors for AD and aberrant metabolic pathways. This Review outlines novel insights from preclinical research that implicate apolipoprotein E, the endocytic system, cholesterol metabolism and microglial activation as Aβ-independent regulators of tau pathology. These factors are discussed in the context of emerging findings from clinical pathology, functional neuroimaging and other approaches in humans. Finally, we discuss the implications of these new insights for current Aβ-targeted strategies and highlight the emergence of novel therapeutic strategies that target processes upstream of both Aβ and tau. In Alzheimer disease, the accumulation of amyloid-β (Aβ) is thought to drive both tau pathology and neurodegeneration. In this Review, van der Kant et al. discuss the evidence for Aβ-independent drivers of tau pathology in Alzheimer disease and the implications for therapeutic development.
         datePublished:2019-11-28T00:00:00Z
         dateModified:2019-11-28T00:00:00Z
         pageStart:21
         pageEnd:35
         sameAs:https://doi.org/10.1038/s41583-019-0240-3
         keywords:
            Alzheimer's disease
            Cortex
            Microglia
            Neurodegeneration
            Biomedicine
            general
            Neurosciences
            Behavioral Sciences
            Biological Techniques
            Neurobiology
            Animal Genetics and Genomics
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41583-019-0240-3/MediaObjects/41583_2019_240_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41583-019-0240-3/MediaObjects/41583_2019_240_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41583-019-0240-3/MediaObjects/41583_2019_240_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41583-019-0240-3/MediaObjects/41583_2019_240_Figa_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41583-019-0240-3/MediaObjects/41583_2019_240_Fig4_HTML.png
         isPartOf:
            name:Nature Reviews Neuroscience
            issn:
               1471-0048
               1471-003X
            volumeNumber:21
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Rik van der Kant
               url:http://orcid.org/0000-0002-7023-0106
               affiliation:
                     name:Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience
                     address:
                        name:Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Amsterdam University Medical Center, Amsterdam Neuroscience
                     address:
                        name:Alzheimer Center Amsterdam Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Lawrence S. B. Goldstein
               affiliation:
                     name:University of California, San Diego
                     address:
                        name:Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, USA
                        type:PostalAddress
                     type:Organization
                     name:Sanford Consortium for Regenerative Medicine
                     address:
                        name:Sanford Consortium for Regenerative Medicine, La Jolla, USA
                        type:PostalAddress
                     type:Organization
                     name:University of California, San Diego
                     address:
                        name:Department of Neurosciences, University of California, San Diego, La Jolla, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rik Ossenkoppele
               affiliation:
                     name:Amsterdam University Medical Center, Amsterdam Neuroscience
                     address:
                        name:Alzheimer Center Amsterdam Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Clinical Memory Research Unit, Lund University
                     address:
                        name:Clinical Memory Research Unit, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Amyloid-β-independent regulators of tau pathology in Alzheimer disease
      description:The global epidemic of Alzheimer disease (AD) is worsening, and no approved treatment can revert or arrest progression of this disease. AD pathology is characterized by the accumulation of amyloid-β (Aβ) plaques and tau neurofibrillary tangles in the brain. Genetic data, as well as autopsy and neuroimaging studies in patients with AD, indicate that Aβ plaque deposition precedes cortical tau pathology. Because Aβ accumulation has been considered the initial insult that drives both the accumulation of tau pathology and tau-mediated neurodegeneration in AD, the development of AD therapeutics has focused mostly on removing Aβ from the brain. However, striking preclinical evidence from AD mouse models and patient-derived human induced pluripotent stem cell models indicates that tau pathology can progress independently of Aβ accumulation and arises downstream of genetic risk factors for AD and aberrant metabolic pathways. This Review outlines novel insights from preclinical research that implicate apolipoprotein E, the endocytic system, cholesterol metabolism and microglial activation as Aβ-independent regulators of tau pathology. These factors are discussed in the context of emerging findings from clinical pathology, functional neuroimaging and other approaches in humans. Finally, we discuss the implications of these new insights for current Aβ-targeted strategies and highlight the emergence of novel therapeutic strategies that target processes upstream of both Aβ and tau. In Alzheimer disease, the accumulation of amyloid-β (Aβ) is thought to drive both tau pathology and neurodegeneration. In this Review, van der Kant et al. discuss the evidence for Aβ-independent drivers of tau pathology in Alzheimer disease and the implications for therapeutic development.
      datePublished:2019-11-28T00:00:00Z
      dateModified:2019-11-28T00:00:00Z
      pageStart:21
      pageEnd:35
      sameAs:https://doi.org/10.1038/s41583-019-0240-3
      keywords:
         Alzheimer's disease
         Cortex
         Microglia
         Neurodegeneration
         Biomedicine
         general
         Neurosciences
         Behavioral Sciences
         Biological Techniques
         Neurobiology
         Animal Genetics and Genomics
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41583-019-0240-3/MediaObjects/41583_2019_240_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41583-019-0240-3/MediaObjects/41583_2019_240_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41583-019-0240-3/MediaObjects/41583_2019_240_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41583-019-0240-3/MediaObjects/41583_2019_240_Figa_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41583-019-0240-3/MediaObjects/41583_2019_240_Fig4_HTML.png
      isPartOf:
         name:Nature Reviews Neuroscience
         issn:
            1471-0048
            1471-003X
         volumeNumber:21
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Rik van der Kant
            url:http://orcid.org/0000-0002-7023-0106
            affiliation:
                  name:Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience
                  address:
                     name:Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Amsterdam University Medical Center, Amsterdam Neuroscience
                  address:
                     name:Alzheimer Center Amsterdam Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Lawrence S. B. Goldstein
            affiliation:
                  name:University of California, San Diego
                  address:
                     name:Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, USA
                     type:PostalAddress
                  type:Organization
                  name:Sanford Consortium for Regenerative Medicine
                  address:
                     name:Sanford Consortium for Regenerative Medicine, La Jolla, USA
                     type:PostalAddress
                  type:Organization
                  name:University of California, San Diego
                  address:
                     name:Department of Neurosciences, University of California, San Diego, La Jolla, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rik Ossenkoppele
            affiliation:
                  name:Amsterdam University Medical Center, Amsterdam Neuroscience
                  address:
                     name:Alzheimer Center Amsterdam Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Clinical Memory Research Unit, Lund University
                  address:
                     name:Clinical Memory Research Unit, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature Reviews Neuroscience
      issn:
         1471-0048
         1471-003X
      volumeNumber:21
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience
      address:
         name:Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands
         type:PostalAddress
      name:Amsterdam University Medical Center, Amsterdam Neuroscience
      address:
         name:Alzheimer Center Amsterdam Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands
         type:PostalAddress
      name:University of California, San Diego
      address:
         name:Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, USA
         type:PostalAddress
      name:Sanford Consortium for Regenerative Medicine
      address:
         name:Sanford Consortium for Regenerative Medicine, La Jolla, USA
         type:PostalAddress
      name:University of California, San Diego
      address:
         name:Department of Neurosciences, University of California, San Diego, La Jolla, USA
         type:PostalAddress
      name:Amsterdam University Medical Center, Amsterdam Neuroscience
      address:
         name:Alzheimer Center Amsterdam Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands
         type:PostalAddress
      name:Clinical Memory Research Unit, Lund University
      address:
         name:Clinical Memory Research Unit, Lund University, Lund, Sweden
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Rik van der Kant
      url:http://orcid.org/0000-0002-7023-0106
      affiliation:
            name:Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience
            address:
               name:Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands
               type:PostalAddress
            type:Organization
            name:Amsterdam University Medical Center, Amsterdam Neuroscience
            address:
               name:Alzheimer Center Amsterdam Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Lawrence S. B. Goldstein
      affiliation:
            name:University of California, San Diego
            address:
               name:Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, USA
               type:PostalAddress
            type:Organization
            name:Sanford Consortium for Regenerative Medicine
            address:
               name:Sanford Consortium for Regenerative Medicine, La Jolla, USA
               type:PostalAddress
            type:Organization
            name:University of California, San Diego
            address:
               name:Department of Neurosciences, University of California, San Diego, La Jolla, USA
               type:PostalAddress
            type:Organization
      name:Rik Ossenkoppele
      affiliation:
            name:Amsterdam University Medical Center, Amsterdam Neuroscience
            address:
               name:Alzheimer Center Amsterdam Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands
               type:PostalAddress
            type:Organization
            name:Clinical Memory Research Unit, Lund University
            address:
               name:Clinical Memory Research Unit, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands
      name:Alzheimer Center Amsterdam Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands
      name:Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, USA
      name:Sanford Consortium for Regenerative Medicine, La Jolla, USA
      name:Department of Neurosciences, University of California, San Diego, La Jolla, USA
      name:Alzheimer Center Amsterdam Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, Netherlands
      name:Clinical Memory Research Unit, Lund University, Lund, Sweden
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(530)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

5.27s.